Libre 2 sensor will be phased out at the end of August 2025.
Find out what you need to do >
* T1DM (Type 1 Diabetes) | T2DM (Type 2 Diabetes) | MDI (multiple daily insulin injections)
The FreeStyle Libre systems^ exist to empower those living with diabetes to make diabetes self-management choices and to help you, as their healthcare professional, to support them in their journey.
Minute-to-minute glucose readings sent to your patient's smartphone◊,ǁ to help them manage their diabetes more confidently.4
Your patients know sooner, can act faster and be ready to avoid hypos with our next-gen continuous glucose monitoring.◊◊
Explore our dedicated Libre Hub for everything you need to get patients started and prescribe the FreeStyle Libre 2 system.
The FreeStyle Libre 2 system is available to prescribe for eligible patients in the UK. Get support accessing the FreeStyle Libre Portfolio for your patients and learn more about the products.
Learn to initiate access to glucose-sensing technology in your local health authority
Read case studies from local health authorities who have initiated access to glucose-sensing technology to reduce health inequalities and improve patient health outcomes.
If you require further information on accessing The FreeStyle Libre systems^ in your area, the Abbott Market Access Team can support you through this process.
Complete our contact form below and an Abbott representative will get in touch.
Education & Learning Centre
Complete interactive, bite-sized eLearning modules designed to help you feel confident in supporting your patients and using the latest techology to achieve better clinical outcomes.
As a registered Healthcare Professional by completing the form below an Abbott representative will contact you regarding your enquiry.
References & Disclaimers
Images are for illustrative purposes only. Not actual patient data.
1. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed Jan 2023.
2. NICE guideline NG28 (2015) Last updated: 29 June 2022; available at https://www.nice.org.uk/guidance/ng28. Accessed Jan 2023.
3. NICE technology appraisal guidance TA943 (2023). Available at https://www.nice.org.uk/guidance/ta943. Accessed April 2024.
4. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
^ FreeStyle Libre Systems refer to FreeStyle Libre 2 and FreeStyle Libre 3 Systems.
◊ The LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
◊◊ The Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with Libreview.
ǁ Glucose readings are automatically displayed in the LibreLink app only when your patients’ smartphone and sensor are connected and in range.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
If you're a healthcare professional located in a different country, please select your country's website from the list of our global sites or contact your local Abbott representative for correct information about the products available in your country.
If you're not a healthcare profressional, click here to go to the FreeStyle Libre consumer website for the UK.
.svg){kind=logo}
Stay connected